Back to search
FDAFDA · Food and drugs·Recall number D-1156-2016

fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR

Published July 13, 2016 · Recall initiated: August 21, 2015

Summary

FDA records drug Class I recall D-1156-2016, published July 13, 2016 and initiated August 21, 2015. Recalling firm: Cantrell Drug Company; Status: Terminated; Reported quantity: a) 564 syringes and b) 1146 syringes; Lot: a) Lots: 148292, exp 11/9/15 and 150610, exp 1/6/16 and b) Lots: 6208, exp 9/16/15 and 6851, exp 1/19/16. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cantrell Drug Company
Distributor
Nationwide
UPC
01003525332144
Lot
a) Lots: 148292, exp 11/9/15 and 150610, exp 1/6/16 and b) Lots: 6208, exp 9/16/15 and 6851, exp 1/19/16
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR recalled?

Yes. FDA published recall D-1156-2016 on July 13, 2016. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 01003525332144.